Selenium status and blood lipids: The cardiovascular risk in young finns study

Journal of Internal Medicine

Volumn 270, Issue 5, 2011, Pages 469-477

  Stranges, S ^a,b   Tabak A G ^b,c   Guallar, E ^d,e   Rayman, M P ^f   Akbaraly, T N ^b,g   Laclaustra, M ^d,e   Alfthan, G ^h   Mussalo Rauhamaa, H ⁱ   Viikari, J S A ^j   Raitakari, O T ^k   Kivimaki M ^b,i  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^f UNIVERSITY OF SURREY   (United Kingdom)

^g INSERM   (France)

^h NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

ⁱ UNIVERSITY OF HELSINKI   (Finland)

^j TURKU UNIVERSITY HOSPITAL   (Finland)

^k UNIVERSITY OF TURKU   (Finland)

more..

Author keywords

Cardiovascular; Cross sectional; Follow up; Lipids; Risk factors; Selenium

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SELENIUM;

ADOLESCENT; ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CHILD; CHOLESTEROL BLOOD LEVEL; FEMALE; FINLAND; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; PRIORITY JOURNAL; SMOKING;

ADOLESCENT; CARDIOVASCULAR DISEASES; CHILD; CHILD, PRESCHOOL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; FEMALE; FINLAND; FOLLOW-UP STUDIES; HUMANS; MALE; RISK FACTORS; SELENIUM; TRIGLYCERIDES;

EID: 80054027567     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2011.02398.x     Document Type: Article

References (46)

1. Rayman MP. Food-chain selenium and human health: emphasis on intake. Br J Nutr 2008; 100: 254-68.
2. Rayman MP. Selenoproteins and human health: Insights from epidemiological data. Biochim Biophys Acta 2009; 1790: 1533-40.
3. Stranges S, Navas-Acien A, Rayman MP, Guallar E. Selenium status and cardio-metabolic health: state of the evidence. Nutr Metab Cardiovasc Dis 2010; 20: 754-60.
4. Burk RF. Selenium, an antioxidant nutrient. Nutr Clin Care 2002; 5: 75-9.
5. Papp LV, Lu J, Holmgren A, Khanna KK. From selenium to selenoproteins: synthesis, identity, and their role in human health. Antioxid Redox Signal 2007; 9: 775-806.
6. Rayman MP. The importance of selenium to human health. Lancet 2000; 356: 233-41.
7. Clark LC, Combs Jr GF, Turnbull BW et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 1996; 276: 1957-63.
8. Combs Jr GF, Gray WP. Chemopreventive agents: selenium. Pharmacol Ther 1998; 79: 179-92.
9. Bleys J, Navas-Acien A, Guallar E. Serum selenium and diabetes in US Adults. Diabetes Care 2007; 30: 829-34.
10. Stranges S, Marshall JR, Natarajan R et al. Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann Intern Med 2007; 147: 217-3.
11. Laclaustra M, Navas-Acien A, Stranges S, Ordovas JM, Guallar E. Serum selenium concentrations and diabetes in US adults: National Health and Nutrition Examination Survey (NHANES) 2003-2004. Environ Health Perspect 2009; 117: 1409-13.
12. Lippman SM, Klein EA, Goodman PJ et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009; 301: 39-51.
13. Bleys J, Navas-Acien A, Stranges S, Menke A, Miller III ER, Guallar E. Serum selenium and serum lipids in US adults. Am J Clin Nutr 2008; 88: 416-23.
14. Laclaustra M, Navas-Acien A, Stranges S, Ordovas JM, Guallar E. Serum selenium levels and hypertension in the US population. Circ Cardiovasc Qual Outcomes 2009; 2: 369-76.
15. Laclaustra M, Stranges S, Navas-Acien A, Ordovas JM, Guallar E. Serum selenium and plasma lipids in US adults: National Health and Nutrition Examination Survey (NHANES) 2003-2004. Atherosclerosis. 2010; 210: 643-8.
16. Stranges S, Laclaustra M, Ji C et al. Higher selenium status is associated with adverse blood lipid profile in British adults. J Nutr 2010; 140: 81-7.
17. Åkerblom HK, Viikari J, Uhari M et al. Atherosclerosis precursors in Finnish children and adolescents. General description of the cross-sectional study of 1980, and an account of the children's and families' state of health. IActa Paediatr Scand Suppl 1985; 318: 49-63.
18. Raitakari OT, Juonala M, Kähönen M et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood - The Cardiovascular Risk in Young Finns Study. JAMA 2003; 290: 2277-83.
19. Varo P, Alfthan G, Ekholm P, Aro A, Koivistoinen P. Selenium intake and serum selenium in Finland: effects of soil fertilization with selenium. Am J Clin Nutr 1988; 48: 342-9.
20. Salonen JT, Alfthan G, Huttunen JK, Pikkarainen J, Puska P. Association between cardiovascular death and myocardial infarction and serum selenium in a matched-pair longitudinal study. Lancet. 1982; 2:175-9.
21. Alfthan G, Aspila P, Ekholm P et al. Nationwide supplementation of sodium selenate to commercial fertilizers. History and 20-year results from the Finnish selenium monitoring program. In: Thompson B, Amoroso L, eds. Combating micronutrient deficiencies: food based approaches, FAO Report 2011 (in press).
22. Kivimäki M, Lawlor DA, Davey SmithG et al. Early socioeconomic position and blood pressure in childhood and adulthood: the Cardiovascular Risk in Young Finns Study. Hypertension 2006; 47: 1-6.
23. Mussalo-Rauhamaa H, Vuori E, Lehto JJ, Akerblom H, Räsänen L. Increase in serum selenium levels in Finnish children and young adults during 1980-1986: a correlation between the serum levels and the estimated intake. Eur J Clin Nutr 1993; 47: 711-7.
24. Viikari J, Ronnemaa T, Seppanen A et al. Serum lipids and lipoproteins in children, adolescents and young adults in 1980-1986. Ann Med 1991; 23: 53-9.
25. Vartiainen E, Laatikainen T, Peltonen M et al. Thirty-five-year trends in cardiovascular risk factors in Finland. Int J Epidemiol 2010; 39: 504-18.
26. Ringstad J, Jacobsen BK, Thomassen Y. The Tromso Heart Study: relationships between the concentration of selenium in serum and risk factors for coronary heart disease. J Trace Elem Electrolytes Health Dis 1987; 1: 27-31.
27. Jossa F, Trevisan M, Krogh V et al. Serum selenium and coronary heart disease risk factors in southern Italian men. Atherosclerosis 1991; 87: 129-34.
28. Suadicani P, Hein HO, Gyntelberg F. Serum selenium concentration and risk of ischaemic heart disease in a prospective cohort study of 3000 males. Atherosclerosis 1992; 96: 33-42.
29. Gamez C, Ruiz-Lopez D, Artacho R, Navarro M, Puerta A, Lopez C. Serum selenium in institutionalized elderly subjects and relation to other nutritional markers. Clin Chem 1997; 43: 693-4.
30. Berr C, Coudray C, Bonithon-Kopp C, Roussel AM, Mainard F, Alperovitch A. Demographic and cardiovascular risk factors in relation to antioxidant status: the EVA Study. Int J Vitam Nutr Res 1998; 68: 26-35.
31. Yang KC, Lee LT, Lee YS, Huang HY, Chen CY, Huang KC. Serum selenium concentration is associated with metabolic factors in the elderly: a cross-sectional study. Nutr Metab. 2010; 7: 38.
32. Rayman MP. Dietary selenium: time to act. BMJ 1997; 314: 387-8.
33. Millen AE, Dodd KW, Subar AF. Use of vitamin, mineral, nonvitamin, and nonmineral supplements in the United States: the 1987, 1992, and 2000 National Health Interview Survey results. J Am Diet Assoc 2004; 104: 942-50.
34. Broadley MR, White PJ, Bryson RJ et al. Biofortification of UK food crops with selenium. Proc Nutr Soc 2006; 65: 169-81.
35. Duffield AJ, Thomson CD, Hill KE, Williams S. An estimation of selenium requirements for New Zealanders. Am J Clin Nutr 1999; 70: 896-903.
36. Stranges S, Marshall JR, Trevisan M et al. Effects of selenium supplementation on cardiovascular disease incidence and mortality: secondary analyses in a randomized clinical trial. Am J Epidemiol 2006; 163: 694-9.
37. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 2007; 297: 842-57.
38. Luoma PV, Sotaniemi EA, Korpela H, Kumpulainen J. Serum selenium, glutathione peroxidase activity and high-density lipoprotein cholesterol--effect of selenium supplementation. Res Commun Chem Pathol Pharmacol 1984; 46: 469-72.
39. Yu SY, Mao BL, Xiao P et al. Intervention trial with selenium for the prevention of lung cancer among tin miners in Yunnan, China. A pilot study. Biol Trace Elem Res 1990; 24: 105-8.
40. Rayman MP, Stranges S, Griffin B, Pastor-Barriuso R, Guallar E. Effect of supplementation with high-selenium yeast on plasma lipids: a randomized, controlled trial. Ann Intern Med 2011; 154: 656-65.
41. Burk RF, Hill KE. Selenoprotein P - expression, functions, and roles in mammals. Biochim Biophys Acta 2009; 1790: 1441-7.
42. Olson GE, Winfrey VP, Hill KE, Burk RF. Megalin mediates selenoprotein P uptake by kidney proximal tubule epithelial cells. J Biol Chem 2008; 283: 6854-60.
43. Sengupta A, Carlson BA, Hoffmann VJ, Gladyshev VN, Hatfield DL. Loss of housekeeping selenoprotein expression in mouse liver modulates lipoprotein metabolism. Biochem Biophys Res Commun 2008; 365: 446-52.
44. Viikari J, Åkerblom HK, Nikkari T et al. Atherosclerosis precursors in Finnish children and adolescents IV. Serum lipids in newborns, children and adolescents. Acta Paediatr Scand Suppl 1985; 318: 103-9.
45. Mueller AS, Mueller K, Wolf NM, Pallauf J. Selenium and diabetes: an enigma? Free Radic Res 2009; 43: 1029-59.
46. Gore F, Fawell J, Bartram J. Too much or too little? A review of the conundrum of selenium. J Water Health 2010; 8: 405-16.